Company / strategic investorRegistered location :Stockholm

Investor ABDeclared Swiss shareholdings

Investor AB: 2 Swiss companies with a declared holding, including ABB Ltd, Newron Pharmaceuticals S.p.A.. Latest filing: 22.08.2023.

Disclosure tracking · company alerts with Pro
Estimated value (CHF)
…
Swiss companies held
2
Largest position
10,03 %
ABB Ltd
12-month trend
Not determinable
0 rate rises · 0 rate falls
Latest filing
22.08.2023
Active since 2002

Declared Swiss portfolio

Latest declared rate per company

Sector allocation

Share of companies held
How to read these figures?

Rates come from the 21 official filings published by SIX Exchange Regulation. A filing is only required when a threshold is crossed (3, 5, 10, 15, 20, 25, 33⅓, 50, 66⅔%): the actual position may have changed since.

Estimated value = shares held per the latest filing × latest CHF closing price. It is an indicative order of magnitude: the position may have changed without a new threshold being crossed, and holdings without a share count or a CHF price are not valued. Each company's mini-chart traces the successive declared rates.

This profile shows only what the declarant published. No external data is added to it.

Group structure

Shareholding disclosures are often filed jointly by several entities of the same group. The registry links them together: "Controls" lists the group entities declared alongside this shareholder, "Controlled by" the head entities. The figure is the number of joint disclosures, followed by the date of the most recent one.

Show group structure3 controls

Controls

Group entities linked to this shareholder in joint disclosures.

This mapping reflects observed disclosures; it does not necessarily indicate permanent legal control.

Disclosure behaviour

Upward and downward threshold crossings show direction, without measuring daily trades below legal thresholds.

90 days · Upward crossings

0

visible history: 19

90 days · Downward crossings

0

visible history: 0

First disclosure: 13.11.2002Last disclosure: 22.08.2023

Nature of disclosed positions

Derivatives, sale positions or lending may indicate a more complex strategy than a long equity holding.

Equity holdings
19

Latest shareholding disclosures

Show 18 older disclosures
PurchaseShareholdings

Accelleron Industries AG

Investor AB · Single shareholder

14.04%Voting rights acquired04.10.2022
PurchaseShareholdings

Newron Pharmaceuticals S.p.A.

Investor AB · Single shareholder

3.013%Voting rights acquired12.05.2020
PurchaseShareholdings

Newron Pharmaceuticals S.p.A.

Investor AB · Single shareholder

1.414%Voting rights acquired12.05.2020
PurchaseShareholdings

Newron Pharmaceuticals S.p.A.

Investor AB · Single shareholder

9.37%Voting rights acquired04.10.2017
PurchaseShareholdings

Newron Pharmaceuticals S.p.A.

Investor AB · Single shareholder

12.47%Voting rights acquired23.01.2016
Below thresholdShareholdings

Newron Pharmaceuticals S.p.A.

Investor AB · Group of shareholders

3%Below threshold23.01.2016
PurchaseShareholdings

ABB Ltd

Investor AB · Group of shareholders

10.03%Voting rights acquired18.11.2015
PurchaseShareholdings

ABB Ltd

Investor AB · Group of shareholders

10.03%Voting rights acquired12.11.2015
PurchaseShareholdings

Newron Pharmaceuticals S.p.A.

Investor AB · Group of shareholders

22.03%Voting rights acquired05.11.2015
PurchaseShareholdings

Newron Pharmaceuticals S.p.A.

Investor AB · Group of shareholders

24.19%Voting rights acquired07.05.2014
PurchaseShareholdings

Newron Pharmaceuticals S.p.A.

Investor AB · Group of shareholders

25.84%Voting rights acquired08.01.2014
PurchaseShareholdings

Newron Pharmaceuticals S.p.A.

Investor AB · Single shareholder

13.35%Voting rights acquired20.04.2013
PurchaseShareholdings

Newron Pharmaceuticals S.p.A.

Investor AB · Group of shareholders

19.96%Voting rights acquired13.03.2013
PurchaseShareholdings

Newron Pharmaceuticals S.p.A.

Investor AB · Group of shareholders

25.63%Voting rights acquired29.01.2013
PurchaseShareholdings

Newron Pharmaceuticals S.p.A.

Investor AB · Group of shareholders

20.64%Voting rights acquired22.12.2012
PurchaseShareholdings

ABB Ltd

Investor AB · Group of shareholders

9.86%Voting rights acquired29.12.2003
PurchaseShareholdings

ABB Ltd

Investor AB · Group of shareholders

10.01%Voting rights acquired03.12.2002
PurchaseShareholdings

ABB Ltd

Investor AB · Group of shareholders

6.83%Voting rights acquired13.11.2002

insider24.ch

Follow Investor AB’s disclosures

Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open

Management purchases in this portfolio

Loading activity…

    These figures aggregate public disclosures. They are not investment advice.

    Common questions

    Which Swiss companies are in Investor AB’s disclosed portfolio?

    ABB Ltd, Newron Pharmaceuticals S.p.A..

    What is Investor AB’s latest disclosure?

    The latest available disclosure was published on 22.08.2023 and concerns Accelleron Industries AG. Threshold disclosures do not describe every purchase or sale.

    Explore further

    Recent insider purchases

    What are insiders doing at companies disclosed by this shareholder?

    All purchases this week

    Insider barometer

    Compare insider purchases and sales across the Swiss stock exchange over 30 days.

    View the Swiss barometer

    These signals are not investment advice.